Class I and III antiarrhythmic drugs: Practical considerations for safe, effective use

Arshad Jahangir, Marshall S. Stanton, Stephen C. Hammill, Win Kuang Shen

Research output: Contribution to journalReview article

Abstract

Pharmacologic therapy continues to play an important role in the management of cardiac arrhythmias. Choosing an antiarrhythmic agent involves understanding the concepts related to arrhythmogenesis, risk stratification of patients, and antiarrhythmic mechanisms as well as the pharmacokinetics and pharmacodynamics of individual antiarrhythmic agents. This review focuses on some practical issues related to antiarrhythmic pharmacologic therapy with individual class I and class III antiarrhythmic agents currently in clinical use in the United States.

Original languageEnglish (US)
Pages (from-to)534-557
Number of pages24
JournalFormulary
Volume33
Issue number6
StatePublished - Dec 1 1998

    Fingerprint

ASJC Scopus subject areas

  • Pharmacology (medical)

Cite this

Jahangir, A., Stanton, M. S., Hammill, S. C., & Shen, W. K. (1998). Class I and III antiarrhythmic drugs: Practical considerations for safe, effective use. Formulary, 33(6), 534-557.